Compounds

CJC-1295 DAC

$69.00

AUD

Buy CJC-1295 DAC Australia

>99% Purity
COA Verified
Research Use Only

A long-acting GHRH analogue incorporating albumin-binding technology for research into sustained receptor signalling and peptide persistence.

In stock

RESEARCH USE ONLY

AMINOSPX products are supplied exclusively for legitimate laboratory, analytical, scientific and in vitro research purposes and are not intended for human or animal consumption.

Product Tested & Verified Independent quality testing and verification.
COA Documentation Quality documentation available where applicable.
Discreet & Secure Shipping Carefully packed for secure Australian delivery.

Overview

CJC-1295 DAC is a synthetic analogue of Growth Hormone-Releasing Hormone (GHRH), distinguished by its Drug Affinity Complex (DAC), an engineered modification designed to interact with circulating albumin and extend the peptide’s molecular persistence.

This albumin-binding design provides researchers with a long-acting GHRH analogue for exploring sustained receptor signalling, peptide pharmacology and how molecular modifications influence the behaviour of peptide-based signalling systems.

AMINOSPX supplies CJC-1295 DAC exclusively for legitimate laboratory, analytical, scientific and in vitro research purposes.

Not intended for human consumption or for medical, therapeutic, diagnostic, veterinary, cosmetic or food use.

Molecular Profile

Molecular Name
CJC-1295 DAC
Chemical Classification
Long-Acting Albumin-Binding GHRH Analogue Peptide
Molecular Formula
C165H269N47O46
Molecular Weight
3647.2 g/mol (approx.)
Length
30 Amino Acids
CAS
446262-90-4
PubChem CID
Not supplied in specification
Form
Lyophilised Powder
Color
White
Purity
>99% (HPLC)
Verification
Third-Party Laboratory Tested
Packaging
Sterile Vial

Research Applications

Long-Acting Albumin-Binding GHRH Analogue Peptide is studied in laboratory and in-vitro research across several areas of scientific interest, including:

Prolonged GHRH Signalling

Studied for sustained GHRH-associated receptor and endocrine signalling.

GH/IGF-1 Axis Research

Used to investigate longer-duration changes in GH-associated and downstream IGF-1 signalling.

Peptide Half-Life Research

Used to study how albumin-binding technology influences peptide persistence and pharmacokinetic behaviour.

Endocrine Signalling Research

Used in laboratory research examining prolonged hypothalamic-pituitary signalling.

Research Disclaimer

Information provided on this page is supplied solely for laboratory, analytical, scientific and in vitro research purposes. Products are not intended for human or veterinary use, and the information provided does not constitute medical, pharmaceutical, healthcare or other professional advice.

Nothing contained on this website should be interpreted as a recommendation regarding the diagnosis, treatment, prevention or management of any disease, condition or health outcome.

Researchers are responsible for determining the suitability of products for their intended laboratory applications and for ensuring compliance with all applicable laws, regulations and institutional requirements.

Storage & Handling

Appropriate storage and laboratory handling help maintain product integrity and research consistency.

Storage Recommendations

  • Store the lyophilised compound sealed and dry below 25°C.
  • Once reconstituted, store at 2–8°C in accordance with the applicable laboratory research protocol.
  • Minimise repeated freeze-thaw cycles.
  • Protect from heat, moisture and direct light.

Handling Recommendations

  • Use appropriate laboratory personal protective equipment (PPE).
  • Follow recognised laboratory procedures appropriate to the intended research application.
  • Avoid contact with eyes or skin, and avoid inhalation or ingestion.
  • Maintain appropriate product identification and laboratory documentation.
  • Dispose of unused material according to institutional procedures and applicable regulations.

Certificate of Analysis (COA)

Where available, the latest Certificate of Analysis (COA) for this product is included within the product gallery and can also be accessed through our COA Library. Certificates are published as laboratory analytical documentation becomes available.

Frequently Asked Questions

What is CJC-1295 DAC?

CJC-1295 DAC is a synthetic GHRH analogue incorporating an engineered Drug Affinity Complex designed to interact with circulating albumin. This modification gives researchers a longer-persisting model for examining GHRH receptor signalling and modified peptide behaviour.

What does DAC mean in CJC-1295 DAC?

DAC stands for Drug Affinity Complex. It is an engineered modification designed to promote albumin interaction, extending the molecular persistence of CJC-1295 and allowing longer-duration GHRH signalling to be studied experimentally.

What research areas is CJC-1295 DAC investigated for?

CJC-1295 DAC provides a research model for examining how prolonged GHRH receptor activity and albumin binding influence peptide signalling over time. This makes it useful for studying sustained endocrine communication, peptide persistence and downstream signalling within controlled experimental models.

How should CJC-1295 DAC be stored?

The lyophilised material should be stored in a sealed, dry environment below 25°C. Where laboratory reconstitution is undertaken, store reconstituted material at 2–8°C. Avoid freeze–thaw cycles to help preserve product integrity.

Certificate of Analysis